Table 2.
Effect size | 95% CI | P value | ||
---|---|---|---|---|
Recurrence-free survival | ||||
Loop used (monopolar as reference) | 0.6 | 0.345 | 1.044 | 0.07 |
Tumor size | 1.012 | 0.994 | 1.03 | 0.18 |
Multifocality | 3.347 | 1.872 | 5.984 | < 0.001 |
Post-operative MMC | 1.697 | 0.793 | 3.631 | 0.17 |
Tumour grade (G1 as reference) | 0.977 | 0.629 | 1.52 | 0.92 |
Tumour stage (Ta as reference) | 1.045 | 0.516 | 2.116 | 0.90 |
Presence of muscle in tumour base sampling | 1.345 | 0.68 | 2.661 | 0.40 |
Progression-free survival | ||||
Loop used (monopolar as reference) | 0.783 | 0.449 | 1.368 | 0.73 |
Tumor size | 1.002 | 0.984 | 1.021 | 0.49 |
Multifocality | 2.205 | 1.235 | 3.935 | 0.07 |
Post-operative MMC | 1.093 | 0.521 | 2.297 | 0.51 |
Tumour grade (G1 as reference) | 1.157 | 0.731 | 1.83 | 0.16 |
Tumour stage (Ta as reference) | 1.152 | 0.573 | 2.317 | 0.39 |
Presence of muscle in tumour base sampling | 1.28 | 0.628 | 2.609 | 0.99 |
MMC = intravesical MMC treatment